More
    Guided Solutions - Connecting Talent With Innovation/div>

    Endogenex raises $50M to advance type 2 diabetes treatment

    Funding
    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D) treatment and support a regulatory filing for the endoscopic system...

    Endogenex raises $50M to advance type 2 diabetes treatment

    Funding
    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...

    Starlight Cardiovascular reports first baby treated with Lifeline system

    Innovation
    Starlight Cardiovascular announced that the first baby in the world received treatment with its Lifeline pediatric stent system. The first implant, performed by Dr. Shabana...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    Clinical Trials
    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Pixee Medical announces CE Mark for Knee+ NexSight

    Regulatory Approvals
    Pixee Medical, a pioneer in Augmented Reality (AR) guidance for orthopedic surgery, announced it has received CE mark for Knee+ NexSight, its new AR-based...

    Get Weekly Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    Innovation

    Regulatory Approvals

    Endogenex raises $50M to advance type 2 diabetes treatment

    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...

    Starlight Cardiovascular reports first baby treated with Lifeline system

    Starlight Cardiovascular announced that the first baby in the world received treatment with its Lifeline pediatric stent system. The first implant, performed by Dr. Shabana...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Pixee Medical announces CE Mark for Knee+ NexSight

    Pixee Medical, a pioneer in Augmented Reality (AR) guidance for orthopedic surgery, announced it has received CE mark for Knee+ NexSight, its new AR-based...

    M&A

    Archives

    Latest articles

    Load more

    Popular categories

    Funding1101Regulatory Approvals993Innovation651Clinical Trials513Mergers & Acquisitions496

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices